Revealing radiotherapy- and chemoradiation-induced pathway dynamics in glioblastoma by analyzing multiple

Jia Zhou1, Chao Chen2, Hua-Feng Li2

  • 1Department of Geratology, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang 310007, P.R. China.

Insights

This study reveals dynamic pathway alterations in glioblastoma (GBM) during radiotherapy and chemoradiation. Identifying a key "dynamic module" offers new system-level insights for GBM therapy development.

Area of Science:

  • Oncology
  • Systems Biology
  • Bioinformatics

Background:

  • Glioblastoma (GBM) progression involves dynamic changes in gene pathway activity and connectivity.
  • Understanding these dynamics is crucial for developing effective GBM treatments.
  • System-level insights into molecular mechanisms are needed for GBM therapy.

Purpose of the Study:

  • Investigate dynamic alterations in pathway activity and connectivity in GBM under radiotherapy and chemoradiation.
  • Provide system-level insights into molecular mechanisms relevant to GBM therapy.
  • Identify key molecular pathways and modules driving GBM progression during treatment.

Main Methods:

  • Constructed two differential co-expression networks (DCNs) using gene expression profiles and protein-protein interaction networks.
  • Applied Pearson correlation coefficient analysis and one-sided t-tests for DCN construction.
  • Utilized significance analysis for candidate modules and module connectivity dynamic score (MCDS) to detect shared and dynamic modules.

Main Results:

  • Identified five shared differential modules across radiotherapy and chemoradiation conditions.
  • Detected one significant "dynamic module" exhibiting notable alterations between treatment conditions.
  • Analyzed DCNs comprising 287 nodes and 1,052 edges, identifying 28 seed genes and seven candidate modules.

Conclusions:

  • Revealed dynamic alterations in shared differential modules in GBM during treatment.
  • Identified a specific dynamic module associated with radiotherapy and chemoradiation.
  • Demonstrated the potential of pathway dynamics analysis for studying GBM pathogenesis and therapy.